Literature DB >> 9593131

Fosfomycin reduces CD15s-related antigen expression of Streptococcus pyogenes.

K Hirota1, K Murakami, K Nemoto, T Ono, T Matsuo, H Kumon, Y Miyake.   

Abstract

We have previously shown the immunological mimicry of human sialyl-Lewis(x) (CD15s) by a surface antigen of Streptococcus pyogenes. This mimicking surface antigen may act as a ligand to the selectin family and may induce antibody production against CD15s on host cells, suggesting a possible role in the pathogenesis of S. pyogenes. In this study, the effects of antibiotics on the CD15s-related antigen expression of S. pyogenes were examined at a concentration below the MIC (sub-MIC). The amounts of CD15s on the surfaces of S. pyogenes cells and on the surfaces of S. pyogenes biofilms were determined by a whole-cell enzyme-linked immunosorbent assay and by laser scanning fluorescence microscopy, respectively, by using an anti-CD15s monoclonal antibody. At the sub-MICs, fosfomycin (1R,2S-1,2-epoxypropyl phosphonic acid), its enantiomer (1S,2R-1,2-epoxypropyl phosphonic acid), and benzylpenicillin significantly inhibited the CD15s expression of all strains studied. The effects of fosfomycin and its enantiomer on biofilms were also observed by scanning electron microscopy. Incubation of S. pyogenes with the sub-MIC of fosfomycin or its enantiomer, which has no antibacterial activity, reduced the amount of CD15s on the biofilm surface and made it smooth. These results suggest that fosfomycin or its enantiomer might be useful for preventing S. pyogenes adherence to human CD15s receptors and the resulting immunological pathogenicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593131      PMCID: PMC105749          DOI: 10.1128/AAC.42.5.1083

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Modulatory effect of antibiotics on cytokine production by human monocytes in vitro.

Authors:  K Morikawa; H Watabe; M Araake; S Morikawa
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 2.  Polysaccharide antigens of Escherichia coli.

Authors:  K Jann; B Jann
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

3.  Apparent viscosity and cortical tension of blood granulocytes determined by micropipet aspiration.

Authors:  E Evans; A Yeung
Journal:  Biophys J       Date:  1989-07       Impact factor: 4.033

Review 4.  Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease.

Authors:  A P Moran; M M Prendergast; B J Appelmelk
Journal:  FEMS Immunol Med Microbiol       Date:  1996-12-01

5.  Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A streptococcal infection.

Authors:  S A Halperin; P Ferrieri; E D Gray; E L Kaplan; L W Wannamaker
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226

6.  Lewisx- and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues.

Authors:  S H Itzkowitz; M Yuan; Y Fukushi; A Palekar; P C Phelps; A M Shamsuddin; B F Trump; S Hakomori; Y S Kim
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

7.  Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line.

Authors:  F W Symington; D L Hedges; S Hakomori
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

8.  Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.

Authors:  T Wagner; B Kreft; G Bohlmann; G Schwieder
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

10.  Changes in the pattern of infection caused by Streptococcus pyogenes.

Authors:  E Gaworzewska; G Colman
Journal:  Epidemiol Infect       Date:  1988-04       Impact factor: 2.451

View more
  4 in total

1.  Characterization of biofilm formation by clinically relevant serotypes of group A streptococci.

Authors:  Cordula Lembke; Andreas Podbielski; Carlos Hidalgo-Grass; Ludwig Jonas; Emanuel Hanski; Bernd Kreikemeyer
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

2.  Biofilm formation by group a streptococci: is there a relationship with treatment failure?

Authors:  Joslyn Conley; Merle E Olson; Linda S Cook; Howard Ceri; Van Phan; H Dele Davies
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

Review 3.  Streptococcus pyogenes biofilms-formation, biology, and clinical relevance.

Authors:  Tomas Fiedler; Thomas Köller; Bernd Kreikemeyer
Journal:  Front Cell Infect Microbiol       Date:  2015-02-11       Impact factor: 5.293

4.  The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target.

Authors:  Jannik Donner; Michael Reck; Simone Bergmann; Andreas Kirschning; Rolf Müller; Irene Wagner-Döbler
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.